EGFR and lung carcinoma: The nano-hybrids could enhance the uptake of ETOs by lung cancer cells and induce apoptosis by inhibiting PI3K-AKT and ERBB signaling pathways, which increased the tumor suppression effect of ETOs by 3-fold.